Description : Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare disorder expressed in
infancy and characterized by isolated thrombocytopenia and megakaryocytopenia with
no physical anomalies (Muraoka et al., 1997). King et al. (2005) proposed a new classification
of CAMT based on the course and outcome of the disease, as exemplified by 20 patients:
CAMT type I (11 patients) was characterized by early onset of severe pancytopenia,
decreased bone marrow activity, and very low platelet counts. CAMT type II (9 patients)
was somewhat milder and characterized by transient increases of platelet counts up
to nearly normal values during the first year of life and an onset of bone marrow
failure at age 3 or later.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the MPL proto-oncogene (thrombopoietin receptor) gene (MPL,
159530.0001);